Major investment firm says membership of key climate initiatives has 'become contested'.
Off-label use and pricing among concerns amid booming market for drugs made by pharma firms such as Novo Nordisk.
Most CA100+ investors were tight-lipped on reports that the energy giant has scrapped its 2030 oil and gas reduction target.
Engagement initiative welcomes new investors including French and Canadian asset owners.
UK and European clients want to know managers' alternative plans, express ‘disappointment’ over dropouts.
Latest departures from collaborative engagement initiative include leading responsible investment firm and B Corp.
Ninth US signatory leaves collaborative engagement initiative amid Republican probe.
Sovereign wealth fund appreciates value generated during Joseph Hooley's tenure, but 'continues to place utmost importance on the protection of shareholder rights'.
Insurance giant, which participated as CA100+ 'supporter', cites 'streamlining' as reason for departure.
Legal affairs committee vote paves way for due diligence directive to move on to a full plenary vote next month.